Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Dianthus Therapeutics, Inc. is actively participating in the 44th Annual J.P. Morgan Healthcare conference, highlighting its commitment to developing next-generation therapies for severe autoimmune diseases [1]. Group 1: Company Overview - Dianthus Therapeutics is a clinical-stage biotechnology company focused on transforming the treatment of severe autoimmune diseases [3]. - The company is based in New York City and Waltham, Massachusetts, and is led by an experienced team of biotech and pharmaceutical executives [3]. - Dianthus aims to deliver transformative medicines for individuals suffering from severe autoimmune and inflammatory diseases [3]. Group 2: Event Participation - CEO Marino Garcia will present a corporate overview at the J.P. Morgan Healthcare conference on January 12, 2026, at 3:00 pm PST / 6:00 pm EST [1]. - The company will also host one-on-one meetings with investors during the conference [1]. - A webcast of the presentation will be available in the "News and Events" section of the Dianthus Therapeutics website [2].